不同健康教育方法在预防高压氧治疗患者中耳气压伤的效果观察

目的探讨在高压氧治疗患者中耳气压伤中实施两种不同的健康教育方法的效果。方法将60例高压氧治疗患者随机分为实验组和对照组。对照组采用常规健康教育方法,实验组采用健康教育路径（按时间顺序在接诊当日、入舱前、入舱后、出舱后运用口头宣教、书面材料宣教、示教、宣传栏介绍、成功病例示范宣教等方式）,比较两组健康教育的效果。结果实验组中耳气压伤的发生率（3．33％）明显低于对照组（30．00％）,实验组对健康教育的满意度（96．67％）明显高于对照组（60．00％）。结论在高压氧治疗中实施健康教育路径可提高患者满意度,加快知识的掌握,预防和减少高压氧治疗患者中耳气压伤的发生。     

中耳气压伤相关因素分析及护理对策

中耳气压伤是最常见的高压氧治疗并发症,常发生在加压过程中,主要是由于环境压力改变引起鼓室内外压强不平衡所致,临床表现为中耳鼓膜的损伤.     

机械通气治疗ARDS过程中发生气压伤的相关因素分析

机械通气治疗急性呼吸窘迫综合征(ARDS)过程中气胸发生率为0～76％,气压伤的发生直接导致ARDS病死率的增加。大潮气量可使ARDS患者通气压力过高,导致肺组织损伤进而形成气压伤。因此,近来多使用低潮气量、低平台压的通气方式。本文通过比较两组ARDS患者机械通气时的压力及容量指标,以探讨气压伤发生的相关因素。     

急诊护士锐器伤的调查分析及预防对策

目的了解急诊护士锐器伤的发生情况及护士对锐器伤的防范措施。方法采用问卷调查法,对13名护士12个月内发生锐器伤的情况进行分析。结果13名护士均发生过锐器伤,76％的护士伤后知道正确处理流程。结论护士锐器伤普遍存在,特别是急诊护士的潜在危险性更大,急诊护士的自身防护更应引起重视。     

输尿管镜下气压弹道碎石术失败原因分析及对策

目的 总结输尿管镜下气压弹道碎石术治疗输尿管结石失败的原因和处理方法.方法 回顾性分析经尿道输尿管镜下气压弹道碎石术治疗617例(658侧)输尿管结石患者中失败77例的临床资料.结果 单次碎石成功率为88.3%(581/658),失败率为11.7%(77/658).其中输尿管口狭窄2例,输尿管扭曲狭窄,输尿管镜难以抵达结石23例,改开放手术;结石上移,进入肾盂46例,放置双J管,术后配合ESWL术治疗;输尿管穿孔6例,4例留置双J管术后配合ESWL术治疗,2例改开放手术.结论 输尿管镜下气压弹道碎石治疗输尿管结石疗效可靠,术前合理选择病例,术中仔细操作,提高手术技巧,并配合其他腔内碎石技术,是提高手术成功率的关键.     

高压氧综合治疗支气管哮喘并发皮质盲一例

1 病例简介患者,男,37岁,因反复发作性喘息30年,加重伴视物不清2d入院.惠者于5岁时接触粉尘后出现喘息,此后反复发作,虽经治疗,控制不理想.入院前2d患者接触敌敌畏后出现喘息,意识丧失,约10h后被他人发现,大小便失禁.经外院给予常压吸氧、解痉平喘等治疗后,患者意识清楚,视物不清.体格检查:呼吸18次/min,血压120/90mmHg(1 mmHg=0.133kPa).     

护士在工作中发生锐器伤的原因与防护对策

大量研究证实护士是发生锐器伤及感染经血液传播疾病的高危职业群体。主要感染如乙肝、丙肝、艾滋病等病毒。故护士特定的工作性质，使护理人员面临着严峻的职业暴露的危险。     

高压氧综合治疗脑梗死偏瘫疗效分析

临床常规药物治疗脑梗死后偏瘫具有一定的疗效,但治疗时间长,恢复慢,严重影响患者的生活.我院采用高压氧(HBO)配合药物、康复理疗治疗脑梗死后偏瘫,取得较好的疗效.     

高压氧治疗脑血管梗塞的疗效分析

目的评价高压氧治疗脑血管梗塞的疗效。方法对311例41—84岁的脑血管梗塞患按年龄。发病到接受高压氧治疗的时间分组，进行高压氧治疗1—5疗程后。根据临床症状和体征改善的程度进行临床疗效分析。结果高压氧治疗对各年龄组的脑血管梗塞患有效率均在95%左右。高压氧治疗越早，疗效越好，疗程一般为3—4个疗程为宜。结论只要选好适应证，诊断无误，治疗及时，疗程充足，高压氧治疗对各种年龄的脑梗塞患均有良好的临床疗效。     

糖尿病足高压氧与非高压氧治疗的疗效对比观察

目的探讨高压氧综合治疗糖尿病足的疗效。方法选择糖尿病病人68例,随机分为高压氧治疗组和对照组各34例,均采用控制血糖、营养末梢神经血管、改善循环、全身应用有效抗生素、局部清创处理等治疗措施。高压氧治疗组在上述治疗的基础上加用高压氧治疗。疗效依据Wagner分级下降情况及自觉症状改善程度评价疗效。结果高压氧治疗组总有效率91.1%,对照组总有效率67.6%,差异有统计学意义(P<0.05)。结论高压氧治疗对糖尿病足有较好的康复价值。     

Effect of self-acupressure on middle ear barotrauma associated with hyperbaric oxygen therapy: A nonrandomized clinical trial

Background:In hyperbaric oxygen therapy (HBOT), a patient is exposed to pure oxygen in a chamber. While HBOT is a long-standing and well-established treatment for a wide variety of medical conditions, one of the main complications is middle ear barotrauma (MEB), which can lead to complaints of ear discomfort, stuffiness or fullness in the ear, and difficulties in equalizing ear pressure. The aim of this study is to evaluate the efficacy of self-acupressure in preventing and reducing the degree of MEB associated with HBOT.Methods:This is a prospective nonrandomized controlled study. A sample of 152 participants will be assigned to 2 groups in a 1:1 ratio. The participants in the control group will receive conventional Valsalva and Toynbee maneuvers, while those in the experimental group will be given additional self-acupressure therapy. The acupoints used will be TE17 (Yifeng), TE21 (Ermen), SI19 (Tinggong), and GB2 (Tinghui). The Modified Teed Classification, symptoms of MEB, and overall ear discomfort levels will be assessed. Data will be analyzed using the Chi-Squared test or t test.Objectives:This study aims to evaluate the efficacy of self-acupressure for preventing and reducing the degree of MEB associated with HBOT.Trial registration:ClinicalTrials.gov Identifier: {"type":"clinical-trial","attrs":{"text":"NCT04311437","term_id":"NCT04311437"}}NCT04311437. Registered on 17 March, 2020.     

Prevention of hyperbaric-associated middle ear barotrauma

STUDY OBJECTIVE: To determine the efficacy of topical nasal decongestant in the prevention of middle ear barotrauma in patients undergoing hyperbaric oxygen therapy. DESIGN: Prospective, parallel, double-blind, randomized trial. SETTING: University-affiliated community hospital emergency department with hyperbaric oxygen facilities. PARTICIPANTS: Sixty patients undergoing hyperbaric oxygen therapy; 30 subjects in each treatment arm. INTERVENTIONS: After randomization, consenting patients were given two sprays of oxymetazoline hydrochloride or sterile water, 15 minutes before hyperbaric oxygen therapy. Collected data included patient demographics, ear examinations before and after hyperbaric oxygen treatment, and subjective ear complaints. The otoscopic appearance of the tympanic membrane was graded according to the amount of hemorrhage in the eardrum, with Teed scores ranging from 0 (symptoms only) to 5 (gross hemorrhage and rupture). RESULTS: The treatment groups were similar with regard to age, sex, and medical history. Ear discomfort during hyperbaric oxygen therapy was present in 63% (19 of 30) of those receiving oxymetazoline versus 67% (20 of 30) of the control group (P = .99). Likewise, both groups had similar Teed scores after hyperbaric oxygen therapy (P = .88). No adverse effects were noted. CONCLUSION: The results of this pilot study suggest that topical decongestants may not be effective in preventing middle ear barotrauma during hyperbaric oxygen therapy.     

Preliminary reports on hyperbaric oxygen therapy in multiple sclerosis

Preliminary clinical examinations comprised 16 patients suffering from multiple sclerosis, the mean duration of the disease 9.33 years, of the manifestations at different stages of the development--evaluated on the basis of Kurtzke scale. The patients were subjected exclusively to the treatment with oxygen hyperbary--all in all 25-30 exposures, with the intervals of 24 hours, under the O2 pressure of 2 ata. The qualification for the purposes of treatment and the classification of the symptoms present were carried out according to Fisher, the results obtained were evaluated in conformity with standard version of the Disability Status Scale of Kurtzke. Apart from the routine clinical and laboratory tests the programme of the examinations included also a quantitative determination of immunoglobulins level, complement activity as well as the determination of T and B lymphocytes. An eminent change for the better was found in 14 afflicted persons, in one patient after 15 exposures a worsening was observed and the treatment was arrested. As to the immunological parameters investigated, a general decrease of IgG, IgM, IgA in serum, increase of the complement fraction and its 50% hemolysis determined activity were observed, whereas quantitatively investigated T and B lymphocytes did not show any typical changes. The authors discuss the results.     

高压氧治疗带状疱疹后遗神经痛的研究进展

带状疱疹后遗神经痛（ PHN）是带状疱疹最常见的并发症,以慢性顽固性疼痛为特征,其发病机制尚未明确,临床上治疗方法较多,但许多患者的疼痛仍未得到充分缓解,或者不能耐受药物的不良反应。高压氧治疗是近年来临床治疗中的一种较新的疗法,具有独特的疗效和优势,该文就近年来高压氧治疗PHN的研究现状及PHN的发病机制进行综述。     

高压氧治疗肾脏疾病的研究进展

高压氧治疗是许多急性、慢性疾病的首选或辅助治疗的方法。新近的研究表明,高压氧治疗对慢性肾炎、肾病综合征、糖尿病性肾病、急性肾功能衰竭、肾脏的缺血再灌注损伤等有着良好的治疗作用,而且对另外一些肾脏相关疾病也显示了潜在的疗效,高压氧治疗在肾脏疾病的治疗中占据着越来越重要的地位。该文对高压氧治疗肾脏疾病的研究进展进行综述。     

Physician adoption of hyperbaric oxygen therapy in the treatment of chronic wounds

Hyperbaric oxygen therapy, a treatment alternative for chronic wounds, has been used for several decades yet little is known about factors that influence physicians to incorporate this therapy into practice. To assess wound care physician knowledge of, attitudes toward, and adoption of hyperbaric oxygen therapy and to identify factors associated with physician adoption of this therapy, a 23-item questionnaire, based on Rogers' diffusion of innovation model, was developed by the authors and distributed to 653 American Academy of Wound Management Board-certified physicians. Of the 246 (43%) physicians in the study population who responded to the study survey, 167 (68%) reported they had used or referred patients for hyperbaric oxygen therapy during the past 12 months. More than half of the respondents reported a relatively high level of familiarity with and a positive attitude toward the effects of hyperbaric oxygen therapy on wound healing. Physician adoption of hyperbaric oxygen therapy was significantly associated with a community of >100,000 residents (adjusted odds ratio = 2.29, 95% confidence interval = 1.05 to 5.04); patient request for hyperbaric oxygen therapy (adjusted odds ratio = 5.38, 95% confidence interval = 2.50 to 11.56); positive attitude toward (adjusted odds ratio = 3.38, 95% confidence interval = 1.49 to 7.66) and high level of familiarity with hyperbaric oxygen therapy (adjusted odds ratio = 5.33, 95% confidence interval = 1.72 to 6.49); and practice location in either Florida or Texas (adjusted odds ratio = 3.44, 95% confidence interval = 1.24 to 9.54). Although the majority of the respondents reported adoption of hyperbaric oxygen therapy, most adopters are concentrated only in a few geographic areas. Despite the limitations of this study, especially the potential effects of sampling and response bias, the results help explain factors that have facilitated and hindered the adoption of this technology into practice.